These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2277736)

  • 1. A comparison of lung lamellar body phospholipids from premature and term infants: is sphingomyelin a contaminant of surfactant?
    Neumann MA; McMurchie EJ; Gibson RA
    Pediatr Pulmonol; 1990; 9(3):162-5. PubMed ID: 2277736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorometric procedure for determining "lamellar body" phospholipids in the particulate fraction of amniotic fluid after filtration.
    Egberts J; Soederhuizen W; Gebhardt DO
    Clin Chem; 1983 Feb; 29(2):362-5. PubMed ID: 6687380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamellar body counts compared with traditional phospholipid analysis as an assay for evaluating fetal lung maturity.
    Neerhof MG; Haney EI; Silver RK; Ashwood ER; Lee IS; Piazze JJ
    Obstet Gynecol; 2001 Feb; 97(2):305-9. PubMed ID: 11165600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitive method for the determination of pulmonary surfactant phospholipid/sphingomyelin ratio in human amniotic fluids for the diagnosis of respiratory distress syndrome by thin-layer chromatography-immunostaining.
    Iwamori M; Hirota K; Utsuki T; Momoeda K; Ono K; Tsuchida Y; Okumura K; Hanaoka K
    Anal Biochem; 1996 Jun; 238(1):29-33. PubMed ID: 8660581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased lung surfactant disaturated phosphatidylcholine in sudden infant death syndrome.
    Gibson RA; McMurchie EJ
    Early Hum Dev; 1988; 17(2-3):145-55. PubMed ID: 3208671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in lung surfactant lipids associated with the sudden infant death syndrome.
    Gibson RA; McMurchie EJ
    Aust Paediatr J; 1986; 22 Suppl 1():77-80. PubMed ID: 3790008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamellar body phospholipid content of amniotic fluid: a possible index of fetal lung maturity.
    Duck-Chong CG
    Ann Clin Biochem; 1979 Jul; 16(4):191-6. PubMed ID: 583392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of lamellar body counts to predict fetal lung maturity in pregnancies complicated by diabetes mellitus.
    DeRoche ME; Ingardia CJ; Guerette PJ; Wu AH; LaSala CA; Mandavilli SR
    Am J Obstet Gynecol; 2002 Oct; 187(4):908-12. PubMed ID: 12388975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental study of a lamellar body fraction isolated from human amniotic fluid.
    Oulton M; Martin TR; Faulkner GT; Stinson D; Johnson JP
    Pediatr Res; 1980 May; 14(5):722-8. PubMed ID: 6892955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods of evaluating fetal lung maturity.
    Brown LM; Duck-Chong CG
    Crit Rev Clin Lab Sci; 1982; 16(2):85-159. PubMed ID: 7032844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamellar body phospholipid content of amniotic fluid and L/S ratio compared in assessing fetal lung maturity.
    Duck-Chong CG; Gupta JM; Storey GN; Houghton CR
    Clin Chem; 1980 May; 26(6):766-9. PubMed ID: 6892793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amniotic fluid lamellar body concentration as a marker of fetal lung maturity at term elective caesarean delivery.
    Walker SP; Chow YY; Ugoni AM; Holberton JR; Smith CL; Permezel MJ
    Aust N Z J Obstet Gynaecol; 2010 Aug; 50(4):358-62. PubMed ID: 20716264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amniotic fluid lamellar body count: a rapid and reliable fetal lung maturity test.
    Dalence CR; Bowie LJ; Dohnal JC; Farrell EE; Neerhof MG
    Obstet Gynecol; 1995 Aug; 86(2):235-9. PubMed ID: 7617355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amniotic lamellar body counts determined with the Sysmex XE-2100 analyzer to predict fetal lung maturity during diabetic and other complicated pregnancies.
    Joutsi-Korhonen L; Aitokallio-Tallberg A; Halmesmäki E; Hämäläinen E
    Scand J Clin Lab Invest; 2010 Sep; 70(5):358-63. PubMed ID: 20509824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of "lamellar body phospholipid" in amniotic fluid as a method for assessing fetal lung maturity.
    Duck-Chong CG; Henderson-Smart DJ; Gupta JM; Hensley WJ
    Clin Chem; 1981 Nov; 27(11):1851-5. PubMed ID: 6895349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of surfactant composition in bronchoalveolar lavage fluid of infants with congenital diaphragmatic hernia and of age-matched controls.
    IJsselstijn H; Zimmermann LJ; Bunt JE; de Jongste JC; Tibboel D
    Crit Care Med; 1998 Mar; 26(3):573-80. PubMed ID: 9504589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory distress syndrome, fetal pulmonary surfactant, and amniotic fluid phospholipid analysis.
    Wenk RE
    Clin Lab Med; 1981 Jun; 1(2):199-213. PubMed ID: 6896681
    [No Abstract]   [Full Text] [Related]  

  • 18. Raised bile acid concentrations in SIDS lungs at necropsy.
    Hills BA; Chen Y; Masters IB; Hills YC
    Arch Dis Child; 1997 Aug; 77(2):120-3. PubMed ID: 9301349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary surfactant. II. In sudden infant death syndrome.
    Hill CM; Brown BD; Morley CJ; Davis JA; Barson AJ
    Early Hum Dev; 1988 Mar; 16(2-3):153-62. PubMed ID: 3378521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of human fetal urine as a source of amniotic fluid phospholipids.
    Bar-Oz B; Arad I
    Fetal Diagn Ther; 1996; 11(4):271-4. PubMed ID: 8823608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.